First meningitis B vaccine could be available in UK next year

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7867 (Published 20 November 2012)
Cite this as: BMJ 2012;345:e7867

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gareth Iacobucci
  1. 1BMJ

The first vaccine for meningitis B is set to become available in the United Kingdom next year after being recommended by the European Medicines Agency.

The agency’s Committee for Medicinal Products for Human Use (CHMP) has granted marketing authorisation for Bexsero, a new vaccine from Novartis intended to immunise people aged 2 months or older against invasive meningococcal disease caused by Neisseria meningitidis group B.

If accepted, the vaccine could become available in the UK next year, subject to approval from the UK Joint Committee for Vaccination and Immunisation, which is currently assessing the vaccine for inclusion …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL